:::

詳目顯示

回上一頁
題名:由AMP v. Myriad Genetics, Inc.案論基因技術創新與專利制度之互動
作者:李治安
書刊名:美國最高法院重要判決之研究. 2010~2013;黃昭元 (主編)
頁次:235-280
出版日期:2015
出版項:臺北:新學林
主題關鍵詞:基因技術專利制度
學門:法律學
資料類型:專書論文
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:3
期刊論文
1.Schilling, Stephen H.(2011)。DNA as Patentable Subject Matter and a Narrow Framework for Addressing the Perceived Problems Caused by Gene Patents。Duke law journal,61(3),731-773。  new window
2.李崇僖(20140100)。再探基因專利問題:美國經驗省思。月旦法學,224,304-307。new window  延伸查詢new window
3.陳文吟(20130400)。由Myriad案探討因應基因專利之合理措施。專利師,13,25-43。new window  延伸查詢new window
4.陳龍昇(20121200)。由美國Bilski v. Kappos案探討商業方法發明之專利適格性。臺北大學法學論叢,84,231-286。new window  延伸查詢new window
5.Carbone, Julia(2010)。DNA Patents and Diagnostics: Not a Pretty Picture。Nature Biotechnology,28,784-791。  new window
6.Chandrasekharan, Subhashini(2014)。Do Recent U.S. Supreme Court Rulings on Patenting of Genes and Genetic Diagnostics Affect the Practice of Genetic Screening and Diagnosis in Prenatal and Reproductive Care?。Prenatal Diagnosis,34,921-926。  new window
7.Gold, E. Richard、Carbone, Julia(2010)。Myriad Genetics: In the Eye of the Policy Storm。Genetics in Medicine,12,S39-S70。  new window
8.Holman, Christopher M.(2012)。Will Gene Patents Derail the Next Generation of Genetic Technologies?: A Reassessment of the Evidence Suggests Not。UMCK Law Review,80(3),563-606。  new window
9.Ingram, Tup(2014)。Association for Molecular Pathology v. Myriad Genetics, Inc.: The Product of Nature Doctrine Revisited。Berkeley Technology Law Journal,29,385-417。  new window
10.Kesselheim, Aaron S.(2013)。Gene Patenting--The Supreme Court Finally Speaks。The New England Journal of Medicine,369,869-875。  new window
11.Kumar, Sapna(2014)。Life, Liberty, and the Pursuit of Genetic Information。Alabama Law Review,65,625-681。  new window
12.Kurts, Ann(2014)。Consequences of the US Supreme Court Decision on Gene Patenting。European Intellectual Property Review,35(11),629-636。  new window
13.Price, W. Nicholson(2012)。Unblocked Future: Why Gene Patents Won't Hinder Whole Genome Sequencing and Personalized Medicine。Cardozo Law Review,33,1601-1631。  new window
14.Rai, Arti(2014)。Diagnostic Patents at the Supreme Court。Marquette Intellectual Property Law Review,18,1-9。  new window
15.Russell, Tiana Leia(2012)。Unlocking the Genome: The Legal Case Against Genetic Diagnostic Patents。Marquette Intellectual Property Law Review,16,81-118。  new window
16.Stem, Richard(2013)。Association for Molecular Pathology v Myriad Genetics: Sieving the Gene Pool。European Intellectual Property Review,35(11),685-690。  new window
17.Torrance, Andrew W.、Kahl, Linda J.(2014)。Bringing Standards to Life: Synthetic Biology Standards and Intellectual Property。Santa Clara High Technology Law Journal,30,199-230。  new window
18.楊智傑、王齊庭(20130700)。人體基因序列與診斷方法之專利適格性--以美國AMP v. USPTO & Myriad Genetics案為中心。生物產業科技管理叢刊,4(2),15-49。  延伸查詢new window
19.Sherkow, Jacob S.(2014)。Preliminary Injunctions Post-Mayo and Myriad。Stanford Law Review Online,67,1-8。  new window
20.Sherkow, Jacob S.(2014)。The Natural Complexity of Patent Eligibility。Iowa Law Review,99,1137-1196。  new window
21.Sunder, Madhavi(2013)。Novartis v. Myriad: The Indian and US Supreme Courts on Patents and Public Health。European Intellectual Property Review,35,711-714。  new window
22.Allison, Malorye(2014)。Myriad Diversifies, Fights Rearguard Action on Patents。Nature Biotechnology,32。  new window
23.Andrews, Lori B.、Paradise, Jordan(2005)。Gene Patents: The Need for Bioethics Scrutiny and Legal Change。Yale Journal of Health Policy, Law, and Ethics,5,403-412。  new window
24.Bakshi, Ashish M.(2014)。Gene Patents at the Supreme Court: Association for Molecular Pathology v. Myriad Genetics。Journal of Law and the Biosciences,7,183-189。  new window
25.Bitton, Miriam(2004)。Patenting Abstractions。NC Journal of Law & Technology,15,153-231。  new window
26.Bogard, Olga(2010)。Comment, Patenting the Human Body: The Constitutionality of Gene Patents and Suggested Remedies for Reform。SMU Law Review,63,1319-1342。  new window
27.Chao, Bernard(2014)。The Infringement Continuum。Cardozo Law Review,35,1359-1413。  new window
28.Cook-Deegan, Robert(2013)。The Next Controversy in Genetic Testing: Clinical Data as Trade Secret?。European Journal of Human Genetics,21,585-589。  new window
29.Dreyfuss, Rochelle Cooper(2014)。Tailing Incentives: A Comment on Hemel and Ouellette's Beyond the Patents-Prizes Debate。Texas Law Review,92,131-144。  new window
30.Fowler, Cydney A.(2010)。Comment, Ending Genetic Monopolies: How the TRIPS Agreement's Failure to Exclude Gene Patents Thwarts Innovation and Hurts Consumers Worldwide。American University International Law Review,25,1073-1105。  new window
31.Georgek, Kevin J.(2014)。A Little Light on the Mayo: Justifying Reversal of the Federal Circuit's Association for Molecular Pathology Decision。Seton Hall Law Review,44,171-206。  new window
32.Ghosh, Samantak(2014)。Comment, The Taking of Human Biological Products。California Law Review,102,511-541。  new window
33.Harrison, Charlotte(2014)。Australian Court Upholds Myriad's Gene Patent。Nature Reviews Drug Discovery,13。  new window
34.Jain, Dipika(2014)。Gene-Patenting and Access to Healthcare: Achieving Precision。Houston Journal of International Law,36,101-146。  new window
35.Kane, Eileen M.(2004)。Splitting the Gene: DNA Patents and the Generic Code。Tennessee Law Review,71,707-767。  new window
36.La Belle, Megan M.(2014)。Against Settlement of (Some) Patent Cases。Vanderbilt Law Review,67,375-441。  new window
37.Lauer, Abigail(2011)。Comment, The Disparate Effects of Gene Patents on Different Categories of Scientific Research。Harvard Journal of Law & Technology,25,179-198。  new window
38.MacKenzie, Sean(2011)。Note, Recognizing the Building Blocks of Life as Products of Nature: Association for Molecular Pathology's Rightful Exclusion of Genetic Information from Patentable Subject Matter。Whittier Law Review,32,367-393。  new window
39.Park, Sandra(2014)。Gene Patents and the Public Interest: Litigation Association for Molecular Pathology v. Myriad Genetics and Lessons Moving Forward。North Carolina Journal of Law & Technology,15,519-536。  new window
圖書
1.楊代華(2008)。生物科技與醫療發明專利。台北:元照出版社。  延伸查詢new window
2.謝銘洋(2011)。智慧財產權法。臺北:元照出版社。  延伸查詢new window
3.Christian, Appelt、Goddar, Heinz、劉孔中(2010)。歐洲專利手冊。臺北市:翰蘆。  延伸查詢new window
4.Nard, Craig Allen(2008)。The Law of Patents。Aspen Publishers。  new window
5.Adelman, Martin J.(2009)。Cases and Materials on Patent Law。MN:West Academic Publishing。  new window
6.Secretary's Advisory Committee on Genetics, Health, and Society, Department of Health and Human Services(2010)。Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests。MD:Secretary's Advisory Committee on Genetics, Health, and Society, Department of Health and Human Services。  new window
7.Mueller, Janice M.(2009)。Patent Law。MD:Wolters Kluwer Law & Business, Inc.。  new window
圖書論文
1.李崇禧(2010)。族群性生醫專利趨勢之社會影響與應有規範。基因體醫學研發創新與智慧財產權。元照。  延伸查詢new window
2.李素華(2010)。從BRCA1省思專利制度對基因檢測發明之專利保護。基因體醫學研發創新與智慧財產權。臺北:元照。  延伸查詢new window
3.李素華、謝銘洋(2010)。生技醫療產業所面對新興專利課題--基因檢測、細胞治療與基因治療之專利保護與權利限制。基因體醫學研發創新與智慧財產權。臺北:元照。  延伸查詢new window
4.Sichelman, Ted(2014)。Funk Forward。Intellectual Property at the Edge: The Contested Contours of IP。Cambridge University Press。  new window
5.李素華(2012)。基因研究成果之專利保護及權利範圍--從美歐新近個案談基因專利權對公共衛生之影響。2011科技發展與法律規範雙年刊。臺北:中研院法律學研究所。  延伸查詢new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top